• {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
    • {%itemName%} {%arrowSpan%}
    • {%selfProduct%}
      • {%languages%}
    • This website is for UK Healthcare Professionals only


      August: Episode 2     Watch time: 25 min

      Psoriasis post-COVID-19: an era of virtual clinics?

      Episode two focuses on psoriasis management and treatment considerations in light of COVID-19, sharing experiences of overcoming challenges in individual clinics, and top tips for optimising clinic set-up and psoriasis management now and into the future.2-4

      Podcast Series Host

      Dr Laura Savage

      University of Leeds and Leeds

      Teaching Hospitals NHS Trust

      Podcast Guest Speakers

      Dr Tony Bewley

      Barts Health NHS Trust,

      The Royal London Hospital and Whipps Cross University Hospitals NHS Trust, London

      Lucy Moorhead

      St John’s Institute of Dermatology,

      Guys Hospital, London


      JULY: Episode 1

      Clinical trial spotlight - risankizumab and secukinumab head-to-head in plaque psoriasis

      AUGUST: Episode 2

      Psoriasis in the time of COVID-19: an era of virtual clinics?             

      SEPTEMBER: Episode 3

      Psoriasis in practice: BAD guideline updates                               

      OCTOBER: Episode 4

      BAD 2020: virtual congress highlights

      NOVEMBER: Episode 5

      Are all IL-23s the same?                    

      DECEMBER: Episode 6

      EADV 2020: congress highlights       


      1. SKYRIZI (risankizumab) Summary of Product Characteristics.
      2. NICE rapid guideline ng169: https://www.nice.org.uk/guidance/ng169 (Accessed August 2020).
      3. PsoProtect. https://psoprotect.org (Accessed August 2020).
      4. BAD risk stratification grid: https://www.bad.org.uk/shared/get-file.ashx?itemtype=document&id=6674 (Accessed August 2020).

      UK-RISN-210513 Date of Preparation: October 2021